ArticleJournal of medical case reports2018

When tyrosine kinase inhibitor sunitinib can be discontinued in metastatic renal cell carcinoma to pancreas: a case report.

Yassir Sbitti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.